Company profile
iBio, Inc.
NASDAQ:IBIOBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07487376 | phase1 | recruiting | 2026-05-24 | 2027-05-01 | iBio, Inc. | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults |
FDA applications (0)
No records yet.